IZO S.r.l
IZO S.r.l is an Italian subsidiary of Vaxxinova International that manufactures and sells veterinary vaccines and diagnostic services for livestock disease prevention, serving poultry and cattle farms and veterinarians across multiple geographies including Europe, the United States, and Sub-Saharan Africa.
- Company typePrivate
- Founded1968
- HeadquartersBrescia, Italy
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What IZO S.r.l does
IZO S.r.l. is an Italian pharmaceutical company incorporated as a single-member limited liability company (S.r.l. a socio unico) headquartered in Brescia, Italy, and operating as the Italian arm of Vaxxinova International, a global animal health group. The company manufactures and sells veterinary drugs, vaccines, and supplements focused on livestock disease prevention, with product lines spanning poultry and cattle vaccines as well as diagnostic services for farm operators.
Core products include Vaxxinova-branded vaccines and diagnostics for production animals, the Avishield poultry vaccines portfolio (eight products acquired from Dechra and sold into 29 countries), and Vaxxon SHS, a live Avian metapneumovirus vaccine that received the first-ever USDA approval for live vaccine importation into the United States. Technology is rooted in biological vaccine development and on-farm diagnostics, supported by in-house R&D capabilities and a 24-person poultry vaccine R&D team based in Zagreb transferred from Dechra. The group also gained licensed and autogenous vaccine production capabilities through the July 2025 acquisition of Deltamune (Pty) Ltd in South Africa.
The business model is B2B, relying on a consultative, direct technical sales motion with veterinarians and animal health professionals rather than publicly disclosed pricing or transactional e-commerce. Revenue is generated through vaccine sales and professional diagnostic services for livestock farms. Customer segmentation is vertical (poultry farms, cattle farms) plus a persona-based segment (veterinarians and animal health professionals). Geographic reach spans Europe (Italy, Croatia), North America (United States), and Africa (South Africa, Sub-Saharan Africa), with the Avishield portfolio marking the widest distribution footprint at 29 countries.
IZO S.r.l firmographics
Firmographics- Name
- IZO S.r.l
- Legal name
- IZO S.r.l. a socio unico
- Website
- https://izo.it
- Company type
- Private
- Founded year
- 1968
- Operating status
- Operating
- Short description
- IZO S.r.l is an Italian subsidiary of Vaxxinova International that manufactures and sells veterinary vaccines and diagnostic services for livestock disease prevention, serving poultry and cattle farms and veterinarians across multiple geographies including Europe, the United States, and Sub-Saharan Africa.
- Ownership category
- akta.pro rank
IZO S.r.l industry classification
Industry- Product category
- Veterinary Pharmaceuticals and Animal Health Vaccines
- NAICS
- Veterinary Services (54194), Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Poultry Vaccines (HLAMAKAC)
- akta.pro secondary industries
- Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Veterinary Vaccines (Biologics) (HLAMAEAL), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM)
Keywords
Where IZO S.r.l is headquartered
LocationHeadquarters
- HQ city
- Brescia
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
IZO S.r.l business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Vaccine Sales: Sale of vaccines for livestock including poultry, cattle, and other farm animals. The company offers an ampio range (wide range) of vaccines for production animals.
- Diagnostic Services: Complete set of diagnostic services for farms to monitor and prevent disease outbreaks in livestock operations.
Go-to-market motion1 record
Distribution channels1 record
IZO S.r.l product offering
Product offeringCore offering
IZO S.r.l manufactures and sells veterinary vaccines and provides diagnostic services for livestock farms. The company offers a wide range of vaccines for production animals (poultry, cattle, and other livestock) along with a complete set of diagnostic services for farm-level disease monitoring and prevention. IZO S.r.l operates as the Italian subsidiary within the Vaxxinova International animal health network.
Product overview
Vaxxinova operates as a unified animal health platform offering vaccines and diagnostic services for livestock farms. The core product portfolio includes vaccines for production animals (poultry, cattle) and comprehensive diagnostic services, supported by a global R&D network. The company expanded its offerings through strategic acquisitions, including the Avishield® poultry vaccines portfolio from Dechra and South Africa's Deltamune. IZO S.r.l serves as the Italian subsidiary within the Vaxxinova network, providing local sales and technical support for the vaccine and diagnostic product lines.
Differentiator
Problem solved
Functional benefit
Products and services
- Vaxxinova Vaccines
Quantifiable outcome
- First-ever USDA approval for live avian metapneumovirus vaccine import into US
Companies that use IZO S.r.l
Customer profileSegments3 records
Ideal customer profiles3 records
IZO S.r.l technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
IZO S.r.l partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Deltamune (Pty) LtdcoreVaxxinova acquired Deltamune from Phatisa in July 2025. Deltamune is a leading Animal Health company in South Africa, specialized in African livestock solutions with in-house R&D and production capabilities for licensed and autogenous vaccines, covering Sub Saharan Africa.
- DechracoreDechra sold the Avishield poultry vaccines portfolio to Vaxxinova. The portfolio consists of 8 products manufactured, marketed and sold into 29 countries. The Dechra poultry vaccine R&D team of 24 people based in Zagreb, Croatia, and corresponding pipeline of potential future products transferred to Vaxxinova.
Scale indicators2 records
Recent moves3 records
Expansion highlights5 records
IZO S.r.l competitors and assessment
Company assessmentDirect peers
- Huvepharma: Bulgarian animal health company with vaccines, anti-infectives, and nutritional products for poultry and livestock. Comparable as a poultry vaccine-focused competitor with similar geographic reach in Europe and emerging markets.
- Dechra Pharmaceuticals: UK-based animal health company that sold its Avishield poultry vaccine portfolio and Zagreb R&D team to Vaxxinova in 2025. Comparable as a former direct peer in poultry vaccines with overlapping technical capabilities.
- Phibro Animal Health: Animal health and nutrition company with a poultry vaccine and health solutions business, including autogenous vaccines. Comparable as a focused poultry/livestock health player competing in similar segments.
- Ceva Santé Animale: French-headquartered animal health company with a leading global poultry vaccine franchise and significant livestock vaccine presence. Directly comparable as a poultry-focused vaccine specialist competing head-to-head with Vaxxinova/Avishield.
Regional players
- Biovac: South African animal vaccine manufacturer focused on livestock and poultry vaccines for the African market. Comparable as a regional peer overlapping with the newly acquired Deltamune operations in Sub-Saharan Africa.
Broad incumbents
- Boehringer Ingelheim Animal Health: Major animal health player with strong poultry, swine, and cattle vaccine franchises globally. Comparable as a broad incumbent offering overlapping vaccines and diagnostic solutions across production animals.
- Elanco Animal Health: Global animal health company with a significant poultry and livestock vaccine portfolio. Comparable as a broad incumbent offering competing vaccines and health solutions in the production animal space.
- Merck Animal Health (MSD Animal Health): Global animal health division of Merck offering a comprehensive portfolio of vaccines, anti-infectives, and parasiticides for poultry, swine, cattle, and companion animals. Directly comparable as a broad incumbent across species and geographies.
- Zoetis: World's largest animal health company offering vaccines, diagnostics, and pharmaceuticals across livestock and companion animals. Highly comparable as a broad incumbent in veterinary vaccines, including poultry and cattle segments where Vaxxinova competes.
Others
- Vaxxinova International: Parent company of IZO S.r.l, the Netherlands-headquartered animal health group operating the global Vaxxinova vaccine and diagnostic platform. Included as the strategic parent whose portfolio and geographic reach define the context for IZO S.r.l's operations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
IZO S.r.l social profiles
Digital presenceIZO S.r.l financial estimates
Financial estimateRevenue estimate
Valuation estimate
IZO S.r.l leadership team
Management profileNumber of profiles
IZO S.r.l subsidiaries and ownership
Company hierarchySubsidiaries1 record
IZO S.r.l funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IZO S.r.l M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IZO S.r.l
What does IZO S.r.l do?
IZO S.r.l manufactures and sells veterinary vaccines and provides diagnostic services for livestock farms. The company offers a wide range of vaccines for production animals (poultry, cattle, and other livestock) along with a complete set of diagnostic services for farm-level disease monitoring and prevention. IZO S.r.l operates as the Italian subsidiary within the Vaxxinova International animal health network.
Is IZO S.r.l a public or private company?
IZO S.r.l is a private company. It is classified as corporate owned and is currently operating.
When was IZO S.r.l founded?
IZO S.r.l was founded in 1968.
Where is IZO S.r.l based?
IZO S.r.l is headquartered in Brescia, Italy, in the Europe region.
How does IZO S.r.l make money?
Two revenue lines are on record. Vaccine Sales are the primary driver. The others are diagnostic Services.
Who are IZO S.r.l's main competitors?
Direct peers on record are Huvepharma, Dechra Pharmaceuticals, Phibro Animal Health and Ceva Santé Animale. Biovac is listed as a regional player. Broad incumbents are Boehringer Ingelheim Animal Health, Elanco Animal Health, Merck Animal Health (MSD Animal Health) and Zoetis. Vaxxinova International is listed as an others.
Does IZO S.r.l have an API?
No public API is recorded for IZO S.r.l.
What industry is IZO S.r.l in?
IZO S.r.l's product category is Veterinary Pharmaceuticals and Animal Health Vaccines. Its primary akta.pro industry code is HLAMAKAC, Poultry Vaccines, with a secondary code of HLAMAKAB, Livestock Vaccines (Cattle, Swine, Sheep & Goats). Its NAICS code is 54194 and its SIC code is 2835.